Author Archive for: Joaquim Bellmunt

About Joaquim Bellmunt

This author has not written his bio yet.
But we are proud to say that Joaquim Bellmunt contributed 2 entries already.

Entries by Joaquim Bellmunt

Editorial: Is angiogenesis still an attractive target in metastatic castration-resistant prostate cancer?

In this issue of BJU International, Karzai et al. [1] report the results of a phase I study of the anti-endoglin antibody TRC105 in patients with metastatic castration-resistant prostate cancer (mCRPC). This is a new anti-angiogenic compound with a unique mechanism of action. Since the introduction of the concept of angiogenesis as a requirement for tumour […]

Editorial: Unveiling the surgical risk associated with neoadjuvant chemotherapy in bladder cancer

In this issue of BJU International, Johnson et al. [1] examine the association between neoadjuvant chemotherapy (NAC) for bladder cancer and 30-day morbidity related to radical cystectomy (RC). Level 1 evidence supports use of cisplatin-based NAC for bladder cancer; a meta-analysis of 11 randomised trials including 3005 patients who received NAC found a 5% absolute increase […]

© 2022 BJU International. All Rights Reserved.